These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29773082)

  • 1. No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients.
    Steffensen LB; Feddersen S; Preil SR; Rasmussen LM
    Cardiovasc Diabetol; 2018 May; 17(1):72. PubMed ID: 29773082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Proteome Analysis Reveals Increased Content of Basement Membrane Proteins in Arteries From Patients With Type 2 Diabetes Mellitus and Lower Levels Among Metformin Users.
    Preil SA; Kristensen LP; Beck HC; Jensen PS; Nielsen PS; Steiniche T; Bjørling-Poulsen M; Larsen MR; Hansen ML; Rasmussen LM
    Circ Cardiovasc Genet; 2015 Oct; 8(5):727-35. PubMed ID: 26371159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basement membrane proteins in various arterial beds from individuals with and without type 2 diabetes mellitus: a proteome study.
    Steffensen LB; Iversen XES; Hansen RS; Jensen PS; Thorsen AF; Lindholt JS; Riber LPS; Beck HC; Rasmussen LM
    Cardiovasc Diabetol; 2021 Sep; 20(1):182. PubMed ID: 34496837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin.
    Coleman CB; Lightell DJ; Moss SC; Bates M; Parrino PE; Woods TC
    Mol Cell Endocrinol; 2013 Jul; 374(1-2):125-9. PubMed ID: 23648338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
    Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
    J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control.
    Santovito D; De Nardis V; Marcantonio P; Mandolini C; Paganelli C; Vitale E; Buttitta F; Bucci M; Mezzetti A; Consoli A; Cipollone F
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1681-5. PubMed ID: 24937531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the differential expression of serum microRNA in type 2 diabetes.
    Ding L; Ai D; Wu R; Zhang T; Jing L; Lu J; Zhong L
    Biosci Biotechnol Biochem; 2016; 80(3):461-5. PubMed ID: 26554942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients.
    Stratz C; Nührenberg T; Fiebich BL; Amann M; Kumar A; Binder H; Hoffmann I; Valina C; Hochholzer W; Trenk D; Neumann FJ
    Thromb Haemost; 2014 May; 111(5):902-11. PubMed ID: 24352417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNA profiling and bioinformatics analysis of patients with type 2 diabetes mellitus in a Chinese population.
    Yang ZM; Chen LH; Hong M; Chen YY; Yang XR; Tang SM; Yuan QF; Chen WW
    Mol Med Rep; 2017 Apr; 15(4):2143-2153. PubMed ID: 28260062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the rs3088442 G>A SLC22A3 Gene Polymorphism and the Role of microRNA 147 in Groups of Adult Pakistani Populations With Type 2 Diabetes in Response to Metformin.
    Moeez S; Riaz S; Masood N; Kanwal N; Arif MA; Niazi R; Khalid S
    Can J Diabetes; 2019 Mar; 43(2):128-135.e3. PubMed ID: 30297296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer.
    Zhou JY; Xu B; Li L
    Drug Dev Res; 2015 Sep; 76(6):263-9. PubMed ID: 26936407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-Cause and Cardiovascular Mortality following Treatment with Metformin or Glyburide in Patients with Type 2 Diabetes Mellitus.
    Raee MR; Nargesi AA; Heidari B; Mansournia MA; Larry M; Rabizadeh S; Zarifkar M; Esteghamati A; Nakhjavani M
    Arch Iran Med; 2017 Mar; 20(3):141-146. PubMed ID: 28287807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling peripheral microRNAs in obesity and type 2 diabetes mellitus.
    Wu L; Dai X; Zhan J; Zhang Y; Zhang H; Zhang H; Zeng S; Xi W
    APMIS; 2015 Jul; 123(7):580-5. PubMed ID: 25912229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should Metformin Remain First-Line Medical Therapy for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease? An Alternative Approach.
    Harrington JL; de Albuquerque Rocha N; Patel KV; Verma S; McGuire DK
    Curr Diab Rep; 2018 Jul; 18(9):64. PubMed ID: 30008022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites.
    Gong W; Xiao D; Ming G; Yin J; Zhou H; Liu Z
    J Diabetes; 2014 Jul; 6(4):279-89. PubMed ID: 24606011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity.
    Riches K; Warburton P; O'Regan DJ; Turner NA; Porter KE
    Cardiovasc Revasc Med; 2014 Apr; 15(3):141-8. PubMed ID: 24642103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of MicroRNA networks in tissue-specific direct and indirect effects of metformin and its application.
    Yang Q; Wang G; Fang D; Gao X; Liang Y; Wang L; Wu J; Zeng M; Luo M
    Biomed Pharmacother; 2022 Jul; 151():113130. PubMed ID: 35598373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Prescription Associated with Reduced Abdominal Aortic Aneurysm Growth Rate and Reduced Chemokine Expression in a Swedish Cohort.
    Unosson J; Wågsäter D; Bjarnegård N; De Basso R; Welander M; Mani K; Gottsäter A; Wanhainen A
    Ann Vasc Surg; 2021 Jan; 70():425-433. PubMed ID: 32619497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus.
    He Y; Ding Y; Liang B; Lin J; Kim TK; Yu H; Hang H; Wang K
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.